![]() |
²úµØ | ÉϺ£ |
±£´æÌõ¼þ | 2.8¡æ |
Æ·ÅÆ | DM |
»õºÅ | DM-D8472 |
ÓÃ; | ¿ÆÑÐÓëʵÑé |
¼ì²â·½·¨ | Îü¸½²â¶¨·¨ |
±£ÖÊÆÚ | 6¸öÔÂ |
ÊÊÓ¦ÎïÖÖ | ´óÊó |
¼ì²âÏÞ | ´óÊó |
ÊýÁ¿ | 1000 |
°ü×°¹æ¸ñ | 96T/48T |
±ê¼ÇÎï | ÎÞ |
Ñù±¾ | ѪÇå,ϸ°û,ϸ°ûÉÏÇåÒº¡¢ÌåÒºµÈ |
Ó¦Óà | ¿ÆÑÐÊÔ¼Á |
ÊÇ·ñ½ø¿Ú | ·ñ |
´óÊóÐÄÄÆëÄ(ANP)øÁªÃâÒßÊÔ¼ÁºÐÌØÒìÐÔÇ¿£¬Öظ´ÐÔºÃ
ÉϺ£óÆÂêÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾elisa¼ì²âÊÔ¼ÁºÐÊÔ¼ÁºÐÓŵã¶à¶à£¬¸ü¼Ó·½±ãÎÒÃǵĿÆÑÐѧÕß½øÐпÆÑ§ÊµÑ飬ÊÇ¿ÆÑÐʵÑéµÄ »ï°é¡£
(1)¡¢¸ßЧ¡¢ÁéÃô¡¢ÌØÒìµÄ¿¹Ì壻
(2)¡¢Îȶ¨µÄÖØ¸´ÐԺͿɿ¿ÐÔ£»
(3)¡¢Îü¸½ÐÔÄܺ㬿հ×ÖµµÍ£¬¿×µ×͸Ã÷¶È¸ßµÄ¹ÌÏàÔØÌ壻
(4)¡¢ÊÊÓÃѪÇ塢Ѫ½¬¡¢×éÖ¯ÔȽ¬Òº¡¢Ï¸°ûÅàÑøÉÏÇåÒº¡¢ÄòÒºµÈµÈ¶àÖֱ걾ÀàÐÍ£»
(5)¡¢½ÚʡʵÑé¾·Ñ¡£
´óÊóÐÄÄÆëÄ(ANP)øÁªÃâÒßÊÔ¼ÁºÐÌØÒìÐÔÇ¿£¬Öظ´ÐÔºÃ
×é³É
(1) 30 ±¶Å¨ËõÏ´µÓÒº 20ml¡Á1 Æ¿ 7 ÖÕÖ¹Òº 6ml¡Á1 Æ¿
(2) ø±êÊÔ¼Á 6ml¡Á1 Æ¿ 8 ±ê׼Ʒ£¨96¦Ìmol/L£© 0.5ml¡Á1 Æ¿
(3) ø±ê°ü±»°å 12 ¿×¡Á8 Ìõ 9 ±ê׼ƷϡÊÍÒº 1.5ml¡Á1 Æ¿
(4) ÑùÆ·Ï¡ÊÍÒº 6ml¡Á1 Æ¿ 10 ˵Ã÷Êé 1 ·Ý
(5)ÏÔÉ«¼ÁA Òº 6ml¡Á1 Æ¿ 11 ·â°åĤ 2 ÕÅ
(6)ÏÔÉ«¼ÁB Òº 6ml¡Á1/Æ¿ 12 ÃÜ·â´ü 1 ¸ö
´óÊóÐÄÄÆëÄ(ANP)øÁªÃâÒßÊÔ¼ÁºÐÌØÒìÐÔÇ¿£¬Öظ´ÐÔºÃ
ELISA¼ì²âÊÔ¼ÁºÐ¼¼ÊõÔÀí
(1). ¿¹Ô»ò¿¹ÌåµÄ¹ÌÏ໯¼°¿¹Ô»ò¿¹ÌåµÄø±ê¼Ç¡£
(2). ½áºÏÔÚ¹ÌÏàÔØÌå±íÃæµÄ¿¹Ô»ò¿¹ÌåÈÔ±£³ÖÆäÃâÒßѧ»îÐÔ¡£
(3). ø±ê¼ÇµÄ¿¹Ô»ò¿¹Ìå¼È±£ÁôÆäÃâÒßѧ»îÐÔ£¬ÓÖ±£ÁôøµÄ»îÐÔ¡£
(4). Êܼì±ê±¾Óë¹ÌÏàÔØÌå±íÃæµÄ¿¹Ô»ò¿¹ÌåÆð·´Ó¦¡£ÔÙ¼ÓÈëø±ê¼ÇµÄ¿¹Ô»ò¿¹Ì壬Ҳͨ¹ý·´Ó¦¶ø½áºÏÔÚ¹ÌÏàÔØÌåÉÏ¡£
(5). ´Ëʱ¹ÌÏàÉϵÄøÁ¿Óë±ê±¾ÖÐÊܼìÎïÖʵÄÁ¿³ÊÒ»¶¨µÄ±ÈÀý¡£
(6). ¼ÓÈëø·´Ó¦µÄµ×Îïºó£¬µ×Îﱻø´ß»¯³ÉΪÓÐÉ«²úÎ²úÎïµÄÁ¿Óë±ê±¾ÖÐÊܼìÎïÖʵÄÁ¿Ö±½ÓÏà¹Ø£¬¹Ê¿É¸ù¾Ý³ÊÉ«µÄÉîdz½øÐж¨ÐÔ»ò¶¨Á¿·ÖÎö¡£²â¶¨·½·¨¾ßÓкܸߵÄÃô¸Ð¶È£¨pg-ng/mlˮƽ£©£¬²¢ÇÒÖØ¸´ÐԺá£ÒÔÃâÒßѧ·´Ó¦Îª»ù´¡£¬½«¿¹Ô¡¢¿¹ÌåµÄÌØÒìÐÔ·´Ó¦Óëø¶Ôµ×ÎïµÄ¸ßЧ´ß»¯×÷ÓÃÏà½áºÏÆðÀ´µÄÒ»ÖÖÃô¸ÐÐԺܸߵÄÊÔÑé¼¼Êõ
´óÊóÐÄÄÆëÄ(ANP)øÁªÃâÒßÊÔ¼ÁºÐÌØÒìÐÔÇ¿£¬Öظ´ÐÔºÃ
óÆÂêÆ·Öʱ£Ö¤
ÊÛǰ£ºÎª¿Í»§Ìá¹©È«Ãæ¼¼Êõ×Éѯ·þÎñ²¢Ìṩ˵Ã÷Ê飬ÈκÎ×Éѯ¶¼»áϸÐĴ𸴣¬ÎÞÂÛ¹ºÂòÓë·ñ¡£
ÊÛºó£ºËùÓеÄelisaÊÔ¼ÁºÐÈçÓÐÖÊÁ¿ÎÊÌ⣬Ãâ·Ñ°ü»»£¬Îª¿Í»§ÌṩÃâ·Ñ´ú²â·þÎñ£¬Ã¿¸ö¼¼ÊõÐÔµÄÎÊÌâ¶¼»áΪÄãÄÍÐĽâ¾ö¡£
´óÊóÐÄÄÆëÄ(ANP)øÁªÃâÒßÊÔ¼ÁºÐÌØÒìÐÔÇ¿£¬Öظ´ÐÔºÃ
´óÊóÐÄÄÆëÄ(ANP)øÁªÃâÒßÊÔ¼ÁºÐÌØÒìÐÔÇ¿£¬Öظ´ÐÔºÃ
Ïà¹Ø²úÆ·
È»ºóÎÒÃÇ´ÓELISAÊÔ¼ÁºÐµÄÐÔÄÜ·½ÃæÈ¥Á˽⣺
DM-D9375
´óÊó΢¹Üµ°°×¾ÛºÏ´Ù½øµ°°×(TPPP)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TPPP (Tubulin Polymerization Promoting Protein) ELISA Kit
96T/48T
DM-D9376
´óÊóÊÜÌ峬¼Ò×å³ÉÔ±1B(TNFRSF1B)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TNFRSF1B (Tumor Necrosis Factor Receptor Superfamily, Member 1B) ELISA Kit
96T/48T
DM-D9377
´óÊó¦Â(TNF-¦Â)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TNF-¦Â (Tumor Necrosis Factor ¦Â) ELISA Kit
96T/48T
DM-D9378
´óÊóÏà¹ØµòÍöÓÕµ¼ÅäÌå1(TRAIL-R1)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TRAIL R1 (Tumor Necrosis Factor Related Apoptosis Inducing Ligand 1) ELISA Kit
96T/48T
DM-D9379
´óÊóÏà¹ØµòÍöÓÕµ¼ÅäÌå3(TRAIL-R3)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TRAIL R3 (Tumor Necrosis Factor Related Apoptosis Inducing Ligand 3) ELISA Kit
96T/48T
DM-D9380
´óÊóÏà¹ØµòÍöÓÕµ¼ÅäÌå4(TRAIL-R4)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TRAIL R4 (Tumor Necrosis Factor Related Apoptosis Inducing Ligand 4) ELISA Kit
96T/48T
DM-D9381
´óÊóÏà¹ØµòÍöÓÕµ¼ÅäÌå(TRAIL/TNFSF10)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TRAIL/TNFSF10 (Tumor Necrosis Factor Related Apoptosis Inducing Ligand) ELISA Kit
96T/48T
DM-D9382
´óÊóµ°°×53(TP53)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TP53 (Tumor Protein 53) ELISA Kit
96T/48T
DM-D9383
´óÊóÌØÒìÉú³¤Òò×Ó/Ïà¹ØÒò×Ó(TSGF)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TSGF (Tumor Specific Growth Factor/Tumor Supplied Group of Factor) ELISA Kit
96T/48T
DM-D9384
´óÊóÀÒ°±Ëáø(TYR)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TYR (Tyrosinase) ELISA Kit
96T/48T
DM-D9385
´óÊóÀÒ°±ËἤøB(TRKB)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TRKB (Tyrosine Kinase B) ELISA Kit
96T/48T
DM-D9386
´óÊóº¬ÃâÒßÇòµ°°×Ñù»·ºÍÉÏÆ¤Éú³¤Òò×ÓÑùÓòÀÒ°±Ëἤø2(Tie-2)øÁªÃâÒßÊÔ¼ÁºÐ
Rat TIE-2 (Tyrosine Kinase With Immunoglobulin-Like And EGF-Like Domains 2) ELISA Kit
96T/48T
DM-D9387
´óÊó¸ßÃô¼××´ÏÙËØ(U-T4)øÁªÃâÒßÊÔ¼ÁºÐ
Rat U-T4 (Ultrasensitivity Thyroxine) ELISA Kit
96T/48T
DM-D9388
´óÊó¸ßÃôÈýµâ¼××´ÏÙÔ°±Ëá(U-T3)øÁªÃâÒßÊÔ¼ÁºÐ
Rat U-T3 (Ultrasensitivity Triiodothyronine) ELISA Kit
96T/48T
DM-D9389
´óÊóºìϸ°ûÑÜÉúºËÒò×Ó2Ñùµ°°×2(NFE2L2)øÁªÃâÒßÊÔ¼ÁºÐ
Rat NFE2L2 (Nuclear Factor, Erythroid Derived 2 Like Protein 2) ELISA Kit
96T/48T
DM-D9390
´óÊóÄò¼¤Ã¸ÐÍÏËÈÜøԼ¤»îÒò×Ó(PLAU/uPA)øÁªÃâÒßÊÔ¼ÁºÐ
Rat PLAU/uPA(Urokinase-Type Plasminogen Activator) ELISA Kit
96T/48T
DM-D9391
´óÊóÄò¼¤Ã¸ÐÍÏËÈÜøԼ¤»îÎïÊÜÌå(PLAUR/uPAR)øÁªÃâÒßÊÔ¼ÁºÐ
Rat PLAUR/uPAR (Plasminogen Activator, Urokinase Receptor) ELISA Kit
96T/48T
DM-D9392
´óÊóÄÚÆ¤Ï¸°ûÉú³¤Òò×ÓB(VEGF-B)øÁªÃâÒßÊÔ¼ÁºÐ
Rat VEGF-B (Vascular Endothelial Cell Growth Factor B) ELISA Kit
96T/48T
DM-D9393
´óÊóÄÚÆ¤Ï¸°ûÉú³¤Òò×ÓC(VEGF-C)øÁªÃâÒßÊÔ¼ÁºÐ
Rat VEGF-C (Vascular Endothelial Cell Growth Factor C) ELISA Kit
96T/48T
DM-D9394
´óÊóÄÚÆ¤Ï¸°ûÉú³¤Òò×ÓD(VEGF-D)øÁªÃâÒßÊÔ¼ÁºÐ
Rat VEGF-D (Vascular Endothelial Cell Growth Factor D) ELISA Kit
96T/48T
DM-D9395
´óÊóÄÚÆ¤Ï¸°ûÉú³¤Òò×ÓÊÜÌå2(VEGFR-2/KDR)øÁªÃâÒßÊÔ¼ÁºÐ
Rat VEGFR-2/KDR (Vascuoar Endothelial Growth Factor Receptor 2) ELISA Kit
96T/48T
DM-D9396
´óÊóÄÚÆ¤Ï¸°ûÕ³¸½·Ö×Ó1(VCAM-1/CD106)øÁªÃâÒßÊÔ¼ÁºÐ
Rat VCAM-1 (Vascuolar Cell Adhesion Molecule 1) ELISA Kit
96T/48T
DM-D9397
´óÊó»îÐÔ³¦ëÄ(VIP)øÁªÃâÒßÊÔ¼ÁºÐ
Rat VIP (Vasoactive Intestinal Peptide) ELISA Kit
96T/48T
DM-D9398
´óÊó³ÙÏÖ¿¹Ô(VLA)øÁªÃâÒßÊÔ¼ÁºÐ
Rat VLA (Very Late Appearing Antigen) ELISA Kit
96T/48T
DM-D9399
´óÊóV-Fos FBJ²¡¶¾°©»ùÒòͬԴÎï(FOS)øÁªÃâÒßÊÔ¼ÁºÐ
Rat FOS (V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog) ELISA Kit
96T/48T
DM-D9400
´óÊóV-Ha-Ras Harvey²¡¶¾°©»ùÒòͬԴÎï(HRAS)øÁªÃâÒßÊÔ¼ÁºÐ
Rat HRAS (V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog) ELISA Kit
96T/48T
1¡¢¼ì²â·¶Î§£º
½¨Á¢ÏßÐÔ·¶Î§£ºÐè²â¶¨9-11¸öŨ¶Èˮƽ£¬Ã¿¸öŨ¶ÈË®Æ½ÖØ¸´²â¶¨3-4´Î¡£
ÑéÖ¤±ê³ÆÏßÐÔ²ÎÊý£ºÐè²â¶¨4-6¸öŨ¶Èˮƽ£¬Ã¿¸öŨ¶ÈË®Æ½ÖØ¸´²â¶¨3-4´Î¡£
ËùÓÐÑù±¾Ó¦ÔÚÒ»´ÎÔËÐÐÖлò¼¸´Î¼ä¸ôºÜ¶ÌµÄÔËÐÐÖÐËæ»ú²â¶¨£¬ ÔÚÒ»ÌìÖ®ÄÚÍê³É¡£
2¡¢ÁéÃô¶È£º
ʾÀý£ºÈË IL-13 µÄ ¿É¼ì²âŨ¶ÈΪ 0.1 pg/ml (6 ´Î¶ÀÁ¢ÊµÑéµÄƽ¾ùÖµ)¡£ 10 ¸öÁã±ê׼ƷŨ¶È OD µÄƽ¾ùÖµ¼ÓÉÏÁ½±¶ SD£¬¼ÆË㠿ɼì²âŨ¶È¡£
×¢Ò⣺ÁéÃô¶È¸ú¼ì²â·¶Î§ µã²»ÏàµÈ¡£
3¡¢Îȶ¨ÐÔ£¨Öظ´ÐÔ¡¢¾«ÃÜÐÔ£©£º
ø±ê°åÄÚ¾«ÃÜ¶È 3 ¸öÒÑ֪Ũ¶ÈµÄÑù±¾Ã¸±ê°åÄÚÖØ¸´²â¶¨ 20 ´Î£¬ÆÀ¹Àø±ê°åÄڵľ«Ãܶȡ£Ã¸±ê°å¼ä¾«ÃÜ¶È 3 ¸öÒÑ֪Ũ¶ÈµÄÑù±¾Ã¸±ê°å¼äÖØ¸´¼ì²â 6 ´Î£¬ÆÀ¹Àø±ê°å¼äµÄ¾«Ãܶȡ£ ÊÔ¼ÁºÐÒ»°ã°åÄÚ±äÒìϵÊýСÓÚ10% £¬°å¼ä±äÒìϵÊýСÓÚ15% £¨Í³¼ÆÑ§¸ÅÄ ËùÓÐÑù±¾Ó¦ÔÚÒ»´ÎÔËÐÐÖлò¼¸´Î¼ä¸ôºÜ¶ÌµÄÔËÐÐÖÐËæ»ú²â¶¨£¬ ÔÚÒ»ÌìÖ®ÄÚÍê³É¡£ ÅúÄÚ¾«ÃܶȣºÊÇÖÚ¶àÖÖÀྫÃܶÈÖÐ×î»ù±¾µÄÒ»¸ö£¬ËüÊÇÔÚÑϸñµÄÏàËÆÌõ¼þÏ£¬ËùµÃµ½µÄ µÄ¾«Ãܶȡ£ Åú¼ä¾«ÃܶȣºÖ¸ÔÚͬһʵÑéÊÒ£¬ÓÉͬһ£¨×飩²Ù×÷Ô±ÔÚͬһÒÇÆ÷ÉÏ£¬Ê¹ÓÃͬһ·½·¨ºÍͬÖÖ¡¢Í¬Ò»ÅúºÅÊÔ¼Á£¬ÔÚÒ»¶Îʱ¼äÄÚ(Ò»°ãΪһ¸öÔ»ò20¸ö¹¤×÷ÈÕ)¶Ôͬһ²âÊÔÑùÆ·£¨³£ÓÃÖÊ¿ØÆ·£©²âÁ¿½á¹ûµÄ¾«Ãܶȡ£ ÎÒÃǵÄÊÔ¼ÁºÐ¿ØÖưåÄÚ£¬ÅúÄÚCVÖµÔÚ10%ÄÚ£¬Åú¼äCVÖµÔÚ15%ÄÚ¡£
4¡¢×¼È·¶È£¨»ØÊÕÂÊ£©£º
ʾÀý£º5 ·Ý½¡¿µÈËѪÇåÖмÓÈë 3 ¸ö²»Í¬Å¨¶ÈˮƽµÄÈË IL-13£¬Î´¼ÓÈË IL-13 µÄѪÇå×÷Ϊ±¾µ×£¬¼ÆËã»ØÊÕÂÊ¡£»ØÊÕÂʵķ¶Î§´Ó 82 %ÖÁ 110 %£¬Æ½¾ù»ØÊÕÂÊΪ 98 %¡£